BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 33812076)

  • 1. Liposome technologies towards colorectal cancer therapeutics.
    Sang R; Stratton B; Engel A; Deng W
    Acta Biomater; 2021 Jun; 127():24-40. PubMed ID: 33812076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of nanoparticles in drug delivery for the treatment of osteosarcoma: focussing on the liposomes.
    Liang W; Dong Y; Shao R; Zhang S; Wu X; Huang X; Sun B; Zeng B; Zhao J
    J Drug Target; 2022 Jun; 30(5):463-475. PubMed ID: 34962448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in liposome formulations for breast cancer therapeutics.
    Yang B; Song BP; Shankar S; Guller A; Deng W
    Cell Mol Life Sci; 2021 Jul; 78(13):5225-5243. PubMed ID: 33974093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Trends in Liposome-based Drug Delivery in Colorectal Cancer.
    Krajewska JB; Bartoszek A; Fichna J
    Mini Rev Med Chem; 2019; 19(1):3-11. PubMed ID: 30179131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered liposomes mediated approach for targeted colorectal cancer drug Delivery: A review.
    Shazleen Ibrahim I; Starlin Chellathurai M; Mahmood S; Hakim Azmi A; Harun N; Ulul Ilmie Ahmad Nazri M; Muzamir Mahat M; Mohamed Sofian Z
    Int J Pharm; 2024 Feb; 651():123735. PubMed ID: 38142874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances and clinical translation of liposomal delivery systems in cancer therapy.
    Chen J; Hu S; Sun M; Shi J; Zhang H; Yu H; Yang Z
    Eur J Pharm Sci; 2024 Feb; 193():106688. PubMed ID: 38171420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in lipid-based nanocarriers for breast cancer metastasis treatment.
    Joun I; Nixdorf S; Deng W
    Front Med Technol; 2022; 4():893056. PubMed ID: 36062261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposome-based diagnostic and therapeutic applications for pancreatic cancer.
    Raza F; Evans L; Motallebi M; Zafar H; Pereira-Silva M; Saleem K; Peixoto D; Rahdar A; Sharifi E; Veiga F; Hoskins C; Paiva-Santos AC
    Acta Biomater; 2023 Feb; 157():1-23. PubMed ID: 36521673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basics to advances in nanotherapy of colorectal cancer.
    Tiwari A; Saraf S; Jain A; Panda PK; Verma A; Jain SK
    Drug Deliv Transl Res; 2020 Apr; 10(2):319-338. PubMed ID: 31701486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges and pitfalls in the development of liposomal delivery systems for cancer therapy.
    Moosavian SA; Bianconi V; Pirro M; Sahebkar A
    Semin Cancer Biol; 2021 Feb; 69():337-348. PubMed ID: 31585213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Last Advances in Nanocarriers-Based Drug Delivery Systems for Colorectal Cancer.
    Rama AR; Jimenez-Lopez J; Cabeza L; Jimenez-Luna C; Leiva MC; Perazzoli G; Hernandez R; Zafra I; Ortiz R; Melguizo C; Prados J
    Curr Drug Deliv; 2016; 13(6):830-8. PubMed ID: 26634791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Light-induced liposomes for cancer therapeutics.
    Chen W; Goldys EM; Deng W
    Prog Lipid Res; 2020 Jul; 79():101052. PubMed ID: 32679153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nano-enabled colorectal cancer therapy.
    Pan Q; Fan X; Xie L; Wu D; Liu R; Gao W; Luo K; He B; Pu Y
    J Control Release; 2023 Oct; 362():548-564. PubMed ID: 37683732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review on liposome-based therapeutic approaches against malignant melanoma.
    Mirzavi F; Barati M; Soleimani A; Vakili-Ghartavol R; Jaafari MR; Soukhtanloo M
    Int J Pharm; 2021 Apr; 599():120413. PubMed ID: 33667562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer.
    Zalba S; Contreras AM; Haeri A; Ten Hagen TL; Navarro I; Koning G; Garrido MJ
    J Control Release; 2015 Jul; 210():26-38. PubMed ID: 25998052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles: Attractive tools to treat colorectal cancer.
    Younis NK; Roumieh R; Bassil EP; Ghoubaira JA; Kobeissy F; Eid AH
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):1-13. PubMed ID: 36028154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress of targeted nanocarriers in diagnostic, therapeutic, and theranostic applications in colorectal cancer.
    Choudhury H; Pandey M; Saravanan V; Mun ATY; Bhattamisra SK; Parikh A; Garg S; Gorain B
    Biomater Adv; 2023 Oct; 153():213556. PubMed ID: 37478770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the Application of Liposomal Nanosystems in Anticancer Therapy.
    Xiao D; Zhou R
    Curr Stem Cell Res Ther; 2021; 16(1):14-22. PubMed ID: 32324519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.